Validated antibody with 45 RRID-verified research citations across 1 target. Reactive in Human.

CD63 (MX-49.129.5)

Santa Cruz BiotechnologyCat# sc-5275
45citations
ApplicationsAsk supplier
Reactivity
Human
HostMouse
ClonalityMonoclonal
Research Usage45citations
View on Santa Cruz BiotechnologyView RRID verification

More CD63 antibodies from other suppliers

Compared on specifications and validation. No paid placements.

CD63 Antibody
CUSABIOCat# CSB-PA120615
Validated · ELISA, WB, IHC
Applications
ELISAWBIHC
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD63 Antibody
CUSABIOCat# CSB-PA006039
Validated · WB, ELISA
Applications
WBELISA
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD63 Antibody
CUSABIOCat# CSB-PA259468
Validated · ELISA, WB, IHC
Applications
ELISAWBIHC
Reactivity
HumanMouse
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD63 Monoclonal Antibody
CUSABIOCat# CSB-MA004950A1mClone: 10F11E6
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIFFC
Reactivity
HumanRabbit
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO
CD63 Monoclonal Antibody
CUSABIOCat# CSB-MA004950A0mClone: 1H1E11
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIFFC
Reactivity
Human
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO
CD63 Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA004950A0HUClone: 2E5
Validated · ELISA, IHC, IF
Applications
ELISAIHCIF
Reactivity
Human
HostRabbit
ClonalityMonoclonal
View datasheet on CUSABIO
Anti-CD63 (Extracellular region) Antibody
OriGeneCat# TA389089Clone: M040
Datasheet specs
Applications
ICCWB
Reactivity
Human
HostMouse
Clonality
View datasheet on OriGene
Anti-CD63 (Extracellular region) Antibody
OriGeneCat# TA389088Clone: M034
Datasheet specs
Applications
ICCIPWB
Reactivity
Human
HostMouse
Clonality
View datasheet on OriGene

+ 25 more CD63 options from other suppliers.

Product verified through the Antibody Registry (RRID). Application and species data from supplier specifications and published research. No paid placements.